Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

  • Birgit Engesæter ,

    birgite@rr-research.no

    Affiliation Department of Tumor Biology, Oslo University Hospital, Oslo, Norway

    ⨯
  • Olav Engebraaten,

    Affiliations Department of Tumor Biology, Oslo University Hospital, Oslo, Norway, Department of Oncology, Oslo University Hospital, Oslo, Norway, Institute for Clinical Research, Medical Faculty, University of Oslo, Oslo, Norway

    ⨯
  • Vivi Ann Flørenes,

    Affiliation Department of Pathology, Oslo University Hospital, Oslo, Norway

    ⨯
  • Gunhild Mari Mælandsmo

    Affiliations Department of Tumor Biology, Oslo University Hospital, Oslo, Norway, Department of Pharmacy, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.